Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV 101 in Major Depressive Disorder
NCT02484456Phase 2Completed
- Sponsor
- National Institute of Mental Health
- Start
- Oct 2015
- Primary completion
- Feb 2019
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of AV-101 in major depressive disorder (MDD), sponsored by National Institute of Mental Health. Started Oct 2015; status: completed.
02
Drugs
AV-101
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02484456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02484456.